Intracranial inoculation on the other hand led to accelerated growth of HIF-1α-deficient tumor growth, whereas VEGF-deficient astrocytomas still exhibited a growth disadvantage. The gene discussed is HIF1A; the disease is astrocytoma (excluding glioblastoma).